舍圖控股(08392.HK)贖回基金權益
格隆匯5月28日丨舍圖控股(08392.HK)此宣佈,於2021年5月28日,公司全資附屬公司逸豐行使其贖回權,並向基金管理人提交書面贖回請求。所贖回基金的未償還本金額為100萬美元。
根據私人配售備忘錄的條款,贖回將於2021年7月1日落實完成,而贖回價格將以下列方式計算:相關估值日估值時刻之該類別資產淨值將除以當時已發行之相關類別參與股份數目。贖回本金額為100萬美元而公司估計贖回收益不多於17,000美元。因此,公司可能自贖回收取的估計總額將不多於1,017,000美元(包括本金額及估計收益)。
贖回完成後,集團不再於基金擁有任何權益。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.